DAIICHI SANKYO
Updates & Highlights
Daiichi Sankyo's trademark win falls short on online-monitoring costs
Daiichi Sankyo's trademark win falls short on online-monitoring costs
MLex · about 8 hours ago
How Daiichi Sankyo aims to become a top five oncology player by 2035
How Daiichi Sankyo aims to become a top five oncology player by 2035
Labiotech.eu · 1 day ago
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
marketscreener.com · 2 days ago
Recent Openings
View all 1 jobsCulture & Mission
Benefits & Perks
Health Insurance
Medical, dental & vision
Remote Work
Work from anywhere flexibility
Learning Budget
Professional development
Competitive Salary
Market-rate compensation
Equity/Stock Options
Ownership in the company
Generous PTO
Paid time off
Tech Stack
Core Values
Innovation
Pushing boundaries in AI/ML technology
Collaboration
Working together to achieve more
Excellence
Striving for the highest quality
Impact
Making a difference in the world
Office Locations
Team
Are you on the team at Daiichi Sankyo?
Claim this company page to verify ownership, edit details, and respond to applicants.
Claim this company →News & Press
20 recentDaiichi Sankyo's trademark win falls short on online-monitoring costs
Daiichi Sankyo's trademark win falls short on online-monitoring costs
MLex · about 8 hours ago
How Daiichi Sankyo aims to become a top five oncology player by 2035
How Daiichi Sankyo aims to become a top five oncology player by 2035
Labiotech.eu · 1 day ago
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
Daiichi Sankyo : Selected as SX Brand for the Third Consecutive Year
marketscreener.com · 2 days ago
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
simplywall.st · 4 days ago
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
Are Daiichi Sankyo Company’s (TSE:4568) ASCO 2026 ADC Data Deepening Its Oncology Moat?
simplywall.st · 4 days ago
Assessing Daiichi Sankyo (TSE:4568) Valuation After Recent Share Price Weakness
Assessing Daiichi Sankyo (TSE:4568) Valuation After Recent Share Price Weakness
simplywall.st · 8 days ago
Assessing Daiichi Sankyo Company (TSE:4568) Valuation After Recent Share Price Weakness
Assessing Daiichi Sankyo Company (TSE:4568) Valuation After Recent Share Price Weakness
Yahoo Finance · 8 days ago
JPMorgan cuts Daiichi Sankyo stock rating on weak outlook
JPMorgan cuts Daiichi Sankyo stock rating on weak outlook
Investing.com · 8 days ago
Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness?
Is It Time To Revisit Daiichi Sankyo (TSE:4568) After Its Recent Share Price Weakness?
simplywall.st · 13 days ago
Daiichi Sankyo concludes pcpa letter of intent for Vanflyta®
Daiichi Sankyo concludes pcpa letter of intent for Vanflyta®
marketscreener.com · 14 days ago
Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta®
Daiichi Sankyo Concludes pCPA Letter Of Intent For Vanflyta®
TradingView · 14 days ago
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
PR Newswire Canada · 14 days ago
Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO
Daiichi Sankyo Presents New Clinical Research And Product Pipeline Updates Across Oncology Portfolio At ASCO
marketscreener.com · 14 days ago
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
Business Wire · 14 days ago
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
Yahoo Finance · 14 days ago
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
Daiichi Sankyo Concludes pCPA Letter of Intent for Vanflyta® in Newly Diagnosed FLT3-ITD Positive AML
Yahoo Finance · 14 days ago
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
Daiichi Sankyo Showcases Progress Across Industry-Leading Oncology Portfolio with Latest Research Updates at ASCO
BioSpace · 14 days ago
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026
Business Wire · 16 days ago
Eyes on Asia: Fosun, Accro Biosciences, Daiichi Sankyo
Eyes on Asia: Fosun, Accro Biosciences, Daiichi Sankyo
BioXconomy · 16 days ago
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026
Daiichi Sankyo Europe Reaffirms Commitment to Patient-Centred Care with Extensive Data Showcase at EAS Congress 2026
Yahoo Finance · 16 days ago